German biotech CatalYm raises €50 million for GDF-15 inhibitor immunotherapyCatalYm has closed a €50 million ($59m) series B financing round to fund clinical studies of its immunotherapy Share XGerman biotech CatalYm raises €50 million for GDF-15 inhibitor immunotherapyhttps://pharmaphorum.com/news/german-biotech-catalym-raises-e50-million-for-gdf-15-inhibitor-immunotherapy/
Health Innovators: David Van Sickle on digital innovation in respiratory medicineIn the first episode of our Health Innovators series, Paul Tunnah speaks to David Van Sickle, CEO of Share XHealth Innovators: David Van Sickle on digital innovation in respiratory medicinehttps://pharmaphorum.com/views-and-analysis/health-innovators-david-van-sickle-on-digitalising-respiratory-medicine/
ANGLE raises £20m, eyes opportunity in immunotherapy trialsLiquid biopsy company ANGLE has raised £20m through a conditional placing on the London Stock Exchange which will Share XANGLE raises £20m, eyes opportunity in immunotherapy trialshttps://pharmaphorum.com/news/angle-raises-20m-eyes-opportunity-for-parsortix-in-immunotherapy-trials/
BMS joins forces with insitro to develop neurodegenerative treatmentsinsitro has landed another big biopharma partnership, signing a five-year collaboration with Bristol Myers Sqibb to develop therapies Share XBMS joins forces with insitro to develop neurodegenerative treatmentshttps://pharmaphorum.com/news/bms-joins-forces-with-insitro-to-develop-neurodegenerative-treatments/
Exact Sciences buys cancer detection company Thrive for $2.15 billionStocks for Exact Sciences leaped 33% after it announced the acquisition of liquid biopsy rival Thrive and UK Share XExact Sciences buys cancer detection company Thrive for $2.15 billionhttps://pharmaphorum.com/news/exact-sciences-buys-early-cancer-detection-company-thrive-for-2-15-billion/
WebMD buys German health information company coliquioWebMD Health Corp. is acquiring coliquio, a digital medical information company for German-speaking health professionals. Coliquio is used Share XWebMD buys German health information company coliquiohttps://pharmaphorum.com/news/webmd-buys-german-health-information-company-coliquio/
NHS strikes another deal with clinical AI company Sensyne HealthSensyne Health has signed a five-year non-exclusive Strategic Research Agreement (SRA) with Milton Keynes University Hospital NHS Foundation Share XNHS strikes another deal with clinical AI company Sensyne Healthhttps://pharmaphorum.com/news/nhs-strikes-another-deal-with-sensyne-health/
Novartis launches digital health hub in CanadaNovartis is opening a new digital health innovation hub in Canada to help develop “scalable, digital solutions” for Share XNovartis launches digital health hub in Canadahttps://pharmaphorum.com/digital/novartis-launches-digital-health-hub-in-canada/
COVID-19 ventilator demand fuels Philips Q3 salesHuge demand for ventilators and patient monitors spurred third quarter sales for Royal Philips, the company announced. The Share XCOVID-19 ventilator demand fuels Philips Q3 saleshttps://pharmaphorum.com/news/covid-19-ventilator-demand-fuels-philips-q3-sales/
